Bioventus shareholders elect four Class I directors, ratify Grant Thornton as auditor for 2022

Bioventus Inc.

Elected Class I directors: McMurry-Heath (60,416,389 for), Neels (56,271,187), Nohra (56,281,977), Vizirgianakis (60,862,412); broker non-votes 7,070,353 each.
Ratified Grant Thornton LLP as independent auditor for 2022 with 67,929,557 for, 89,283 against, 6,345 abstained (no broker non-votes).
Annual Meeting had 68,025,185 shares present (88.5% of outstanding common stock).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.